Purpose We aimed to research the feasibility of droplet digital PCR (ddPCR) for the quantitative and active recognition of EGFR mutations and then era sequencing (NGS) for verification EGFR-tyrosine kinase inhibitors (EGFR-TKIs) resistance-relevant mutations in circulating tumor DNA (ctDNA) from advanced lung adenocarcinoma (ADC) sufferers. plethora ( 5.15%) (PFS, median, 15.4 vs. 11.1 months, =… Continue reading Purpose We aimed to research the feasibility of droplet digital PCR